You can buy or sell Intec Pharma and other stocks, options, ETFs, and crypto commission-free!
Intec Pharma Ltd. Ordinary Shares, also called Intec Pharma, is a clinical-stage biopharmaceutical company, which focuses on developing drugs based on its proprietary Accordion Pill platform technology. Read More Its product pipeline includes four product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa, which is being developed for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients; Accordion Pill Zaleplon, which is being developed for the treatment of insomnia, including sleep induction and the improvement of sleep maintenance; an Accordion Pill that is being developed for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug which induces ulcers; and AP-CBD/THC, an Accordion Pill with the two primary cannabinoids contained in Cannabis sativa, cannabidiol and tetrahydrocannabinol, which is being developed for various indications including low back neuropathic pain and fibromyalgia. The company was founded by Zvi Joseph in 2000 and is headquartered in Jerusalem, Israel.
52 Week High
52 Week Low
Seeking AlphaMar 1
Intec Pharma files for $200M mixed shelf offering; shares down 3% after hours
Intec Pharma (NASDAQ:NTEC) has filed a preliminary prospectus for a $200M mixed shelf offering. Shares are down 3% after hours....
Markets InsiderFeb 28
Intec Pharma to Participate at Four Investment Conferences in March
JERUSALEM, Feb. 28, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today announces that Company management will participate at the following upcoming investment conferences in March. Cowen 39th Annual Health Care Conference Date: March 11-13, 2019 Company Presentation: Monday, March 11, 2019 at 2:10 pm (Eastern time) Location: Boston Marriott Copley Place, Boston, MA Presenter: Jeffrey A. Meckler, Vice Chairman and Chief Executive Officer of Intec Pharma Format: Corpo...
Stock Price, News, & Analysis for Intec Pharma
Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company's lead product candidate is Accordion Pill Carbidopa/Levodopa (AP-CDLD), which is in a Phase III clinical trial for the treatme...
Expected May 14, Pre-Market